Neuroendocrinology News

Evidence for a direct link between fetal brain response and maternal insulin resistance points to obesity and diabetes risks being pre-programmed in the womb, according to study results published in Diabetologia.

Children and adolescents older than 8 years when diagnosed with type 1 diabetes showed weaker brain activity later in life compared with those diagnosed earlier in life, according to findings presented by University of Pittsburgh Schools of Health Sciences researchers at the annual meeting of the American Psychosomatic Society.

MONTREAL — Pediatric endocrinologists should be aware of the possible consequences of exposure to brominated flame retardants in the everyday environment, according to a presenter at the annual meeting of the Canadian Pediatric Endocrine Group.

In a recent pilot study, researchers observed an increase in urinary exposure to bisphenol A, or BPA, after continuous handling of receipts for 2 hours without gloves.

Lower morning cortisol reactivity and higher evening salivary cortisol levels may indicate frailty in older patients, according to data.

In patients with craniopharyngiomas, complex treatments were predictive of postoperative visual dysfunction while diabetes insipidus was associated with greater rates of anterior pituitary hormone dysfunction and an increased weakness for gender-independent weight gain, according to data published in the Journal of Clinical Endocrinology and Metabolism.

In patients with hypopituitarism, a 2-year regimen of growth hormone therapy does not confer greater benefits in bone mineral density upon those receiving glucocorticoid therapy, according to recent study findings.

Intensive blood pressure and fibrate therapy did not reduce cognitive decline among patients with long-standing type 2 diabetes at risk for cardiovascular events, according to new data from the ACCORD MIND substudy.

Depression and eating disorders were significantly associated with diabetes diagnosis, according to recently published data in Diabetologia.

Recent study data show that women receiving thyroid-stimulating hormone-suppressive doses of levothyroxine do not exhibit signs of central nervous system dysfunction, but levothyroxine replacement-treated hypothyroid patients appear to have slight reductions in overall health and mood.